MatriceLab Innove announced that the first large-scale randomized controlled trial investigating endometrial immune profiling showed that personalized treatment based on immune testing can significantly increase live birth rates from IVF. The trial showed that patients receiving personalized care based on MatriceLab’s UTIMPRO endometrial immune profiling test had a live birth rate (LBR) of 41.4%, compared with 29.7% for those in a control group receiving conventional care. Frontiers in Immu...

Quectel Wireless Solutions, a global IoT solutions provider, today announces the launch of its 5G transparent antenna, the YFCX001WWAH, an innovative solution designed to improve connectivity while maintaining seamless device design. The YFCX001WWAH transparent antenna combines efficiency, transparency, and adaptability, offering manufacturers greater flexibility in device design while ensuring seamless 5G connectivity. This press release features multimedia. View the full release here: https:/...

MEMX, a technology-driven exchange operator founded by members to benefit all investors, today announced the appointment of David Mellor as the company’s Head of Global Market Technology Sales. Mellor will be based in London and focus on the continued build-out of the company’s market technology business while prioritizing its international expansion. Prior to joining MEMX, Mellor spent four years at the London Stock Exchange Group, most recently leading the technology transformation of its FX...

The world’s largest independent healthcare marketing agency Klick Health today announced it acquired Ward6 Singapore’s operations. Through the acquisition, Klick is expanding Singapore’s largest independent life sciences agency, known for defining excellence in healthcare professional (HCP) marketing and medical communications. The move also strengthens Klick’s leadership and client portfolio in the Asia-Pacific (APAC) region and underscores the award-winning global agency’s ongoing expansion a...

BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced the U.S. Food and Drug Administration (FDA) has approved TEVIMBRA® (tislelizumab-jsgr), in combination with platinum-containing chemotherapy, for the first-line treatment of adults with unresectable or metastatic esophageal squamous cell carcinoma (ESCC) whose tumors express PD-L1 (≥1). “The approval of TEVIMBRA in combination with chemothera...

Global cloud communications platform Infobip has released its latest Messaging Trends Report, which reveals that the adoption of Rich Communication Services (RCS) messaging has skyrocketed, transforming the customer experience landscape. Infobip analyzed more than 530 billion interactions on its platform between businesses and consumers in 2024 to identify the latest global business messaging trends. The data suggests Apple’s support for RCS, following its iOS 18 update in late 2024, contribut...

The NAGA Group AG (XETRA: N4G, ISIN: DE000A161NR7), provider of the all-in-one financial SuperApp, has successfully launched the integration of shares listed on the Bucharest Stock Exchange (BSE) into its investment platform. With this expansion of its product portfolio, NAGA becomes the first global retail broker to provide direct access to Romanian shares, facilitating retail investments on the BSE on an international scale. In doing so, NAGA is enabling its customers to diversify their portf...